Cargando…
Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity
The authors present the case of an 80-year-old female with myelodysplastic syndrome treated with chemotherapy and apixaban, a direct oral anticoagulant who suffered an intracranial hemorrhage. She presented to the emergency department with altered mental status and was found to have a large intrapar...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741993/ https://www.ncbi.nlm.nih.gov/pubmed/36514613 http://dx.doi.org/10.7759/cureus.31385 |
_version_ | 1784848435615105024 |
---|---|
author | Prasad, Sathwika Colon Figueroa, Paola Stead, Thor S Mangal, Rohan K Ganti, Latha |
author_facet | Prasad, Sathwika Colon Figueroa, Paola Stead, Thor S Mangal, Rohan K Ganti, Latha |
author_sort | Prasad, Sathwika |
collection | PubMed |
description | The authors present the case of an 80-year-old female with myelodysplastic syndrome treated with chemotherapy and apixaban, a direct oral anticoagulant who suffered an intracranial hemorrhage. She presented to the emergency department with altered mental status and was found to have a large intraparenchymal hematoma with a significant mass effect. Our patient was given FEIBA (Factor Eight Inhibitor Bypass Activity) to reverse the hemorrhage. Anticoagulant-related bleeding reversal strategies are discussed. |
format | Online Article Text |
id | pubmed-9741993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-97419932022-12-12 Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity Prasad, Sathwika Colon Figueroa, Paola Stead, Thor S Mangal, Rohan K Ganti, Latha Cureus Emergency Medicine The authors present the case of an 80-year-old female with myelodysplastic syndrome treated with chemotherapy and apixaban, a direct oral anticoagulant who suffered an intracranial hemorrhage. She presented to the emergency department with altered mental status and was found to have a large intraparenchymal hematoma with a significant mass effect. Our patient was given FEIBA (Factor Eight Inhibitor Bypass Activity) to reverse the hemorrhage. Anticoagulant-related bleeding reversal strategies are discussed. Cureus 2022-11-11 /pmc/articles/PMC9741993/ /pubmed/36514613 http://dx.doi.org/10.7759/cureus.31385 Text en Copyright © 2022, Prasad et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Emergency Medicine Prasad, Sathwika Colon Figueroa, Paola Stead, Thor S Mangal, Rohan K Ganti, Latha Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title_full | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title_fullStr | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title_full_unstemmed | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title_short | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity |
title_sort | intraparenchymal hematoma with significant mass effect treated with factor eight inhibitor bypass activity |
topic | Emergency Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741993/ https://www.ncbi.nlm.nih.gov/pubmed/36514613 http://dx.doi.org/10.7759/cureus.31385 |
work_keys_str_mv | AT prasadsathwika intraparenchymalhematomawithsignificantmasseffecttreatedwithfactoreightinhibitorbypassactivity AT colonfigueroapaola intraparenchymalhematomawithsignificantmasseffecttreatedwithfactoreightinhibitorbypassactivity AT steadthors intraparenchymalhematomawithsignificantmasseffecttreatedwithfactoreightinhibitorbypassactivity AT mangalrohank intraparenchymalhematomawithsignificantmasseffecttreatedwithfactoreightinhibitorbypassactivity AT gantilatha intraparenchymalhematomawithsignificantmasseffecttreatedwithfactoreightinhibitorbypassactivity |